Blood Glucose Probability Prediction Using Kernel Density Estimation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Traditional spot monitoring blood glucose measurements provide limited insight into glucose dynamics and risks of adverse events due to sparse data, leading to a loss of resolution and inadequate understanding of problematic time periods for diabetes management.

Innovation Solution

A method and system using kernel density estimation and Bayes' rule to determine the probability of blood glucose values being in adverse ranges, applying different kernel bandwidths for hypoglycemia and hyperglycemia, enabling accurate prediction of adverse events and informing therapy adjustments.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of operation

If spot monitoring blood glucose measurements are used, then the measurement method is simple and easy to perform, but the data is sparse and provides limited insight into glucose dynamics

Engineering Contradiction:
Improveease of measurementVSAvoidloss of glucose dynamics information
Core Design Contradiction:
Ease of operationVSLoss of information

Solution Approach 1:

The patent introduces kernel density estimation as an intermediary statistical method that bridges sparse spot monitoring measurements and continuous glucose dynamics. The KDE algorithm processes the limited spot measurements and generates a continuous probability density function that represents glucose levels throughout the day, effectively mediating between the simple measurement approach and comprehensive glucose information

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent transforms the parameter representation from discrete spot measurements to continuous probability density functions. By changing how glucose data is represented (from individual time-point values to continuous distributions), the system extracts more information from the same sparse measurements, enabling identification of problematic time periods without requiring more frequent measurements

Inventive Principle:
Principle #35Parameter changes

2Reliability

If measurements are grouped into large time slots to obtain feasible statistics, then statistical analysis becomes possible, but resolution is lost

Engineering Contradiction:
Improvestatistical feasibilityVSAvoidtemporal resolution
Core Design Contradiction:
ReliabilityVSMeasurement precision

Solution Approach 1:

The patent replaces static time slot grouping with dynamic kernel density estimation that adapts to the actual distribution of glucose measurements. Instead of forcing measurements into fixed hourly or quarter-daily bins, the KDE method dynamically creates continuous probability distributions that reflect the true temporal patterns, maintaining both statistical reliability and temporal precision

Inventive Principle:
Principle #15Dynamics

3Measurement precision

If different kernel bandwidths are applied for hypoglycemia and hyperglycemia, then prediction accuracy for adverse events is improved, but computational complexity increases

Engineering Contradiction:
Improveprediction accuracyVSAvoidcomputational complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent applies different kernel bandwidths for different glucose ranges (hypoglycemia vs. hyperglycemia), making the analysis locally optimized for each condition. This local quality approach recognizes that different glucose states require different levels of smoothing in the density estimation, improving prediction accuracy for adverse events while keeping the overall system relatively simple through targeted differentiation

Inventive Principle:
Principle #3Local quality

Data Source

PatentUS20210252220A1Method and system of determining a probability of a blood glucose value for a patient being in an adverse blood glucose range at a prediction time
Publication Date: 2021.08.19 MYSUGR GMBH
  • US20210252220A1 patent drawing
  • US20210252220A1 patent drawing
  • US20210252220A1 patent drawing

AI summary

A method of determining a probability that a patient's blood glucose value is in an adverse range at a prediction time. Spot monitoring blood glucose measurement data is provided and includes blood glucose measurement values and associated measurement times. The values include first and second sets assigned to first and second adverse ranges, respectively. A kernel density estimation and Bayes' rule are used to determine the probability of the blood glucose value of the patient being in the first and second adverse blood glucose ranges at the prediction time. In the kernel density estimation, a first kernel bandwidth is applied for all or some of the first blood glucose measurement values and a second kernel bandwidth different from the first kernel bandwidth is applied for all or some the second blood glucose measurement values. Output data is provided indicative of the prediction time and the probability at the prediction time.